Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Executives
Pharma
Alexis Borisy sheds 2 board jobs to stay with Blueprint
Blueprint installed a director resignation policy after Alexis Borisy's reelection last year without a majority shareholder vote sparked concerns.
Angus Liu
Apr 30, 2024 7:20am
Novartis nominates ex-BMS chief Caforio as its next chair
Apr 23, 2024 2:44am
Amgen CEO nabs pay raise thanks to Horizon deal
Apr 18, 2024 5:08pm
Biogen CEO's 2023 pay shrank by 87%
Apr 16, 2024 1:00pm
Lonza poaches Siegfried's Wolfgang Wienand as new CEO
Apr 2, 2024 11:06am
Once again, AstraZeneca encounters CEO pay pushback
Apr 1, 2024 12:57pm